• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cancer cachexia and the rate of whole body lipolysis in man.

作者信息

Jeevanandam M, Horowitz G D, Lowry S F, Brennan M F

出版信息

Metabolism. 1986 Apr;35(4):304-10. doi: 10.1016/0026-0495(86)90145-9.

DOI:10.1016/0026-0495(86)90145-9
PMID:3959902
Abstract

While malnutrition attending cancer cachexia may be associated with variable losses of body fat, lipid metabolism has been only minimally studied. To clarify potential aberrations of lipid metabolism in weight losing cancer patients, the whole body rate of lipolysis was determined in 9 cancer patients in the postabsorptive state and compared to that in 5 normal subjects. A primed-three stage infusion of glycerol was used to measure plasma glycerol clearance and turnover. A positive correlation between glycerol turnover and plasma concentration was demonstrated in both cancer patients (r = 0.72) and in normal subjects (r = 0.81). Glycerol turnover rate in cancer patients (2.05 +/- 0.14 mumol X kg-1 X min-1) was not different from that in normals (2.31 +/- 0.50); while glycerol clearance in cancer patients (1.72 +/- 0.13 L/min) was significantly lower (P less than 0.025) by 32% than that in normals. This study demonstrates that the whole body lipolytic rate in cancer patients is not different from healthy normals. As a consequence, the loss of body fat in patients with cancer cachexia may be due to a reduced rate of lipogenesis rather than augmented lipolysis as is observed in nonmalignant malnutrition, starvation, or injury.

摘要

相似文献

1
Cancer cachexia and the rate of whole body lipolysis in man.
Metabolism. 1986 Apr;35(4):304-10. doi: 10.1016/0026-0495(86)90145-9.
2
Whole body lipid and energy metabolism in the cancer patient.癌症患者的全身脂质与能量代谢
Metabolism. 1987 Oct;36(10):958-63. doi: 10.1016/0026-0495(87)90132-6.
3
Glycerol dynamics in weight-losing cancer patients.
Surgery. 1985 Feb;97(2):176-84.
4
Cancer cachexia and protein metabolism.癌症恶病质与蛋白质代谢
Lancet. 1984 Jun 30;1(8392):1423-6. doi: 10.1016/s0140-6736(84)91929-9.
5
Free fatty acid metabolism and obesity in man: in vivo in vitro comparisons.人体中游离脂肪酸代谢与肥胖:体内与体外比较
Metabolism. 1986 Jun;35(6):505-14. doi: 10.1016/0026-0495(86)90006-5.
6
Whole-body lipolysis and triglyceride-fatty acid cycling in cachectic patients with esophageal cancer.食管癌恶病质患者的全身脂肪分解及甘油三酯-脂肪酸循环
J Clin Invest. 1990 Nov;86(5):1403-8. doi: 10.1172/JCI114854.
7
Mechanism of increased lipolysis in cancer cachexia.癌症恶病质中脂肪分解增加的机制。
Cancer Res. 2007 Jun 1;67(11):5531-7. doi: 10.1158/0008-5472.CAN-06-4585.
8
Increased catabolic activity in adipose tissue of patients with chronic heart failure.慢性心力衰竭患者脂肪组织代谢活性增加。
Eur J Heart Fail. 2013 Oct;15(10):1131-7. doi: 10.1093/eurjhf/hft067. Epub 2013 May 21.
9
Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance.脂解在脂质周转、癌症恶病质和肥胖引起的胰岛素抵抗中的作用。
Trends Endocrinol Metab. 2014 May;25(5):255-62. doi: 10.1016/j.tem.2014.03.002. Epub 2014 Apr 11.
10
Cardiovascular and metabolic response to adrenaline infusion in weight-losing patients with and without cancer.
Clin Physiol. 1989 Oct;9(5):427-39. doi: 10.1111/j.1475-097x.1989.tb00997.x.

引用本文的文献

1
Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose lipogenesis.胰腺癌恶病质由甲状旁腺激素相关蛋白(PTHrP)驱动的脂肪生成破坏介导。
bioRxiv. 2025 Jun 7:2025.06.03.657464. doi: 10.1101/2025.06.03.657464.
2
Sustained Glucose Turnover Flux Distinguishes Cancer Cachexia from Nutrient Limitation.持续的葡萄糖周转通量可区分癌症恶病质与营养限制。
bioRxiv. 2025 May 20:2025.05.15.654370. doi: 10.1101/2025.05.15.654370.
3
Leucine Supplementation in Cancer Cachexia: Mechanisms and a Review of the Pre-Clinical Literature.
亮氨酸补充治疗癌症恶病质:机制及临床前文献综述。
Nutrients. 2022 Jul 9;14(14):2824. doi: 10.3390/nu14142824.
4
Diverging metabolic programmes and behaviours during states of starvation, protein malnutrition, and cachexia.在饥饿、蛋白质营养不良和恶病质状态下,代谢方案和行为出现分歧。
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1429-1446. doi: 10.1002/jcsm.12630. Epub 2020 Sep 28.
5
Cisplatin-Induced Skeletal Muscle Dysfunction: Mechanisms and Counteracting Therapeutic Strategies.顺铂诱导的骨骼肌功能障碍:机制与治疗策略的对抗。
Int J Mol Sci. 2020 Feb 13;21(4):1242. doi: 10.3390/ijms21041242.
6
Chemotherapy diminishes lipid storage capacity of adipose tissue in a preclinical model of colon cancer.化疗降低结肠癌临床前模型中脂肪组织的脂类储存能力。
Lipids Health Dis. 2017 Dec 19;16(1):247. doi: 10.1186/s12944-017-0638-8.
7
Potential Biomarkers of Fat Loss as a Feature of Cancer Cachexia.作为癌症恶病质特征的脂肪减少的潜在生物标志物。
Mediators Inflamm. 2015;2015:820934. doi: 10.1155/2015/820934. Epub 2015 Oct 5.
8
Evidence and mechanisms of fat depletion in cancer.癌症中脂肪消耗的证据及机制
Nutrients. 2014 Nov 19;6(11):5280-97. doi: 10.3390/nu6115280.
9
Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice.胃饥饿素抑制雄性小鼠顺铂诱导的脂类分解代谢和体重减轻。
Endocrinology. 2013 Sep;154(9):3118-29. doi: 10.1210/en.2013-1179. Epub 2013 Jul 5.
10
Computational modeling of cancer cachexia.癌症恶病质的计算模型
Curr Opin Clin Nutr Metab Care. 2008 May;11(3):214-21. doi: 10.1097/MCO.0b013e3282f9ae4d.